FDA approves new type of nonopioid painkiller for acute pain
14 hours ago · The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. ... In a statement, Dr. Jacqueline Corrigan-Curay, the acting director for the FDA's Center for Drug ...
FDA approves Journavx, new non-opioid painkiller from Vertex: …
14 hours ago · Nonetheless, Vertex executives say Journavx’s ability to soothe pain without the risk of addiction will likely make it a blockbuster, a drug that generates sales of at least $1 billion a year.
FDA approves Vertex's first-in-class non-opioid analgesic for acute ...
1 day ago · Jacqueline Corrigan-Curay, J.D., M.D., acting director of the FDA's Center for Drug Evaluation and Research, stated that the approval of Journavx is an important public health milestone in acute ...
La FDA aprueba el primer analgésico no opioide de su clase de …
1 day ago · La FDA otorgó a Journavx las designaciones de Terapia Innovadora, Vía Rápida y Revisión Prioritaria. La aprobación de Journavx fue concedida a Vertex Pharmaceuticals Incorporated.
La FDA approuve le premier analgésique non opioïde de Vertex …
1 day ago · La FDA a accordé à Journavx les désignations de thérapie révolutionnaire, de procédure accélérée et d'examen prioritaire. L'approbation de Journavx a été accordée à Vertex Pharmaceuticals Incorporated. Cet article a été généré et traduit avec l'aide de l'IA et revu par un rédacteur. Pour plus d'informations, consultez nos T&C.
FDA approva il primo analgesico non oppioide di Vertex per il …
1 day ago · La FDA ha concesso a Journavx le designazioni di Terapia Innovativa, Fast Track e Revisione Prioritaria. L'approvazione di Journavx è stata concessa a Vertex Pharmaceuticals Incorporated. Questo articolo è stato generato e tradotto con il supporto dell'intelligenza artificiale e revisionato da un redattore. Per ulteriori informazioni ...
U.S. Food and Drug Administration
The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the...
Undaunted Vertex closes in on FDA nod for non-opioid pain drug
Oct 28, 2024 · Fast-forward to today, and Vertex Pharmaceuticals is on the verge of gaining an FDA approval for suzetrigine (VX-548), a nonaddictive oral treatment that is on track to become the first major...
Drug Safety Communications | FDA
The FDA's Drug Review Process: Ensuring Drugs Are Safe and Effective; Frequently Asked Questions about the FDA Drug Approval Process; Think It Through: Managing the Benefits and Risks of...
FDA genehmigt Vertex' neuartiges nicht-opioides Schmerzmittel …
1 day ago · Die FDA hat Journavx die Bezeichnungen Breakthrough Therapy, Fast Track und Priority Review verliehen. Die Zulassung von Journavx wurde Vertex Pharmaceuticals Incorporated erteilt.